Ryman Healthcare 2024 ASM Executive Chair Address
Ryman Healthcare 2024 Annual Shareholder Meeting Executive Chair
Address
1 August 2024
SLIDE 1: ANNUAL SHAREHOLDER MEETING (HOLDING PAGE)
SLIDE 2: AGENDA
Good morning everyone and welcome to Ryman Healthcare’s 2024 Annual
Shareholder Meeting.
My name is Dean Hamilton.
I joined the Board in June last year, becoming Chair in August. Following the
resignation of former Group CEO Richard Umbers in April this year, I
transitioned to an Executive Chair role. This is a temporary role until a new
Group CEO is in place.
As Chair, it is my pleasure to welcome all shareholders to the meeting both here
in person, and online.
I would also like to welcome all the Ryman team who have joined us today,
including members of our Senior Executive Team.
Joining me this morning on stage are fellow directors Anthony Leighs, Paula Jeffs,
James Miller, Geoff Cumming, Claire Higgins, Kate Munnings and David Pitman.
Also on stage are Deborah Marris, our Group General Counsel and Company
Secretary and Rob Woodgate, our Group Chief Financial Officer.
For today’s proceedings:
I will provide an overview of the last financial year and an outlook.
Following this we will move to the meeting resolutions, of which we have three.
And then onto general business where you will have the opportunity to ask
questions.
Following the conclusion of the meeting we invite you to join us for refreshments
afterwards.
SLIDE 3: VIRTUAL MEETING INSTRUCTIONS
You will have a chance to ask questions and vote on each of the meeting
resolutions as they are considered.
I will provide further instructions as we move through the meeting.
However, if you encounter any issues, please refer to the virtual portal guide
or you can phone the helpline on 0800 200 220.
You can send through your questions at any time via the online portal by clicking
the link shown here on screen.
I would encourage you to do so as early as possible as this will allow us to answer
these questions at the appropriate time during the meeting.
Voting on the resolutions will be conducted by way of a poll.
For shareholders joining us in person today, you would have validated or been
given your shareholder voting card.
If you are a shareholder and did not register on arrival and wish to vote, please
make your way to the registration desk outside the room and staff from MUFG
Corporate Markets will assist you.
Shareholders joining online will be able to cast a vote using the electronic voting
card received when online registration is validated.
To vote, you will need to click on the “Get a Voting Card” button within the
online meeting platform, which is shown here.
You will be asked to enter your Shareholder or Proxy Number to validate your
voting card.
Voting will remain open until 5 minutes after the conclusion of the meeting.
The Company Secretary has confirmed to me that the Notice of Meeting has
been sent to shareholders and other persons entitled to receive it.
We have not received any apologies.
The Company's constitution prescribes a quorum of shareholders. Based on the
information from the registrar, I can confirm that we have a quorum present.
Proxies have been appointed for the purposes of this meeting in respect of
approximately 417 million shares, representing approximately 61 percent of the
total number of shares.
I’d like to thank shareholders for participating in today’s meeting.
My fellow directors and I will vote all discretionary proxies we have received in
favour of the resolutions as set out in the Notice of Meeting.
As detailed in the Notice of Meeting all directors unanimously support each
resolution.
Our Annual Report for the year ended 31 March has been circulated to
shareholders. This is available online on the investor’s section of our website
and the NZX. Copies are also available in the foyer.
SLIDE 4: EXECUTIVE CHAIR’S ADDRESS
There is no doubt that we are in a period of change as Ryman embarks on getting
fit for the future.
Whilst Ryman continues to set the benchmark for retirement living and quality
of care for our residents, in terms of returns to shareholders we have fallen well
short in recent years. Rest assured, as a Board and management team we are
very focused on improving our financial performance which we believe over time
should be reflected in an improved share price.
As we embark on our new future, we are clear on two things - our residents
remain at the heart of everything we do – because without delighted residents
there is no Ryman - and secondly our villages are the place where we create
value – that is where our assets are, that is where we deliver our services.
Everything else we do is in support of these two guiding principles.
As we highlighted at our recent result, we are refining our strategy and driving
an improvement programme that will place much stronger emphasis on our
financial performance, while maintaining our commitment to purpose-driven
care and exceptional resident experience. We know we need to create a more
sustainable balance between care and financial performance.
We are focusing on three areas for financial improvement:
1. improving the performance of our existing villages;
2. improving the efficiency of our new developments and;
3. creating a sustainable and fit for purpose overhead structure to support our
village and new development activities.
We need to get fit for the future!
I’m looking forward to working with the team, and eventually our new Group
CEO, as we focus intently on restoring our financial performance and with that
our returns to shareholders.
More on these areas later.
SLIDE 5: BOARD OF DIRECTORS
There has been significant change at both Board and management.
Over the past 15 months, three directors have retired from the Board and four
new directors have been appointed, demonstrating our commitment to refresh
our Board membership and bringing new capability and experience to governing
your company.
Of the four new directors, two of those were appointed post the Annual
Shareholder Meeting last year. Both of those directors are therefore up for re-
election today.
Kate Munnings joined the Board on 1 November 2023. Kate brings extensive
commercial healthcare experience from her CEO role at Virtus and COO role
at Ramsay in Australia, where she oversaw the operation of 80 hospitals. Earlier
in her career Kate held senior roles in construction and facilities management.
David Pitman joined the Board on 1 May of this year. He brings strong leadership,
strategic and transformation experience across a range of sectors, including
retirement living in Australia. David has held senior roles at Boston Consulting
Group in Australia and the United States as well as at Stockland Group.
I’m delighted that we have been able to attract two new directors of the quality
of Kate and David.
In addition to these two new Board members, Dr Bernadette Eather has joined
Ryman’s Clinical Governance committee as a Clinical Advisor. Bernadette
started her role on 2 April 2024, replacing Dr David Kerr who retired at 31
March 2024.
Bernadette is a highly regarded clinical governance professional in Australia.
She is the Chief Nurse and Clinical Service Director for Ramsay Health Care,
prior to which she was the NSW Director of Patient Safety at the Clinical
Excellence Commission. She brings valuable external oversight and input to
our clinical governance processes.
We have also made several changes to Board committee memberships and all
of these committees now have new chairs – James chairs Audit, Finance, & Risk,
Paula chairs People, Safety and Remuneration, Kate chairs Clinical Governance
and Anthony chairs Governance & Nominations.
We have also established a temporary Board oversight committee to oversee
my performance during my time as Executive Chair. Paula chairs that as the lead
independent director and is supported by James and Anthony.
2024 will also see the retirement of two directors. Geoff Cumming will be
retiring at the end of today’s meeting. Geoff re-joined the Board in 2018 having
been a substantial shareholder in Ryman since listing in 1999. Geoff has been a
passionate supporter of Ryman for a long period of time and I’m sure will
continue to stay close to the company. On behalf of the Board, Geoff, I would
like to thank you for your significant contribution.
Claire Higgins will be stepping down at the end of the calendar year after 10
years on the Board. Claire stepped into the role of Interim Chair in November
2022 and was instrumental in the capital raise and the subsequent Board renewal.
Claire, whilst it is premature to say farewell, as this will be your last ASM, it is
appropriate to thank you for your contribution particularly over the last 18
months.
There has also been significant change in our senior leadership team over the
last year.
In April 2024, we announced that Group CEO Richard Umbers had resigned. I’d
like to thank Richard for his energy and commitment during his time leading
Ryman.
The search for a new Group CEO is well underway. Our goal, all going well, is
to have someone physically in the seat by the end of this calendar year.
In November 2023 we appointed Rob Woodgate as our new Group Chief
Financial Officer. Rob joined us from Fulton Hogan where he was Group CFO
and has a strong track record as a senior finance leader, bringing a wealth of
experience to the role at an important time for the business.
A number of longstanding employees have left in the last 12 months. I’d like to
take the opportunity to thank them all for their efforts.
SLIDE 6: FINANCIAL PERFORMANCE
Changing our financial performance metrics
Ryman has traditionally used underlying profit as the key measure of its financial
performance. We now believe that there are better indicators of performance
that are also more closely tied to our audited financial accounts. We have turned
our focus to three key financial performance metrics:
1. Cash flow from existing operations;
2. Cash flow from development activity; and
3. Net profit before tax and fair value movements per share.
The first two are cash measures. We believe cash flow, like in any traditional
business, is the most objective measure of performance over time.
Existing operations and new developments have very different performance
drivers and cash flows and we believe are best reported on separately.
The combination of these two measures we term as free cash flow.
Net profit before tax and fair value movements measures the operating
performance of the existing operations. It excludes development activities, the
refinancing gains on Occupation Rights and the unrealised valuation movement
in the portfolio between the start and finish of the year. The latter will fluctuate
year to year and over time and we believe, whilst it is very relevant to the growth
in shareholders’ equity, it is unrealised (as we don’t sell the underlying properties
to residents, we instead grant a right to occupy).
FY24 Financial results
Our financial results for the year ended 31 March 2024 were disappointing on a
number of fronts.
On the positive side, we reported an 18% increase in revenue to $689.9 million,
driven by growth in care, village and deferred management fees primarily as our
new villages continue to mature.
However, the combined impact of impairments and other one-off costs, some
$283.9 million in total, has led to a significant reduction in reported net profit
after tax to $4.8 million against the $257.8 million achieved in FY23.
This result was achieved against a particularly challenging operating environment
with residential property markets subdued and cost inflation impacting all areas
of the business.
We took the necessary decision to reassess the carrying value of our land bank
sites in light of the current economic environment and with a higher hurdle on
whether they could be financially successful new developments. This led to two
sites being deemed unsuitable at Karori and Kohimarama (and these will be put
up for sale in coming months) and two sites that had started but been paused
now written down and brought back into the land bank (at Ringwood and
Takapuna).
Despite these non-cash write-downs, it was pleasing that we achieved an
improvement in cash flow from existing operations to $43.3 million (compared
to -$8.5 million in FY23). Contributing to this was a record number of resale
settlements of occupation rights, which continues to underline the attractiveness
of the Ryman offering.
Ryman achieved an underlying profit of $270.0 million, down 11% on the $301.9
million achieved in the prior year, and within our February 2024 guidance range
of $265–285 million. The reduction in underlying profit on FY23 was primarily a
result of lower margins on new developments which have suffered from higher
costs to complete through construction inflation, the impact of delays and higher
interest costs.
SLIDE 7: CAPITAL MANAGEMENT
We are committed to prudent capital management. The Board made the
decision during the year to suspend dividends. The need to continue to spend
capital to complete committed village buildings and the desire to limit increased
borrowings being key factors behind what I believe to be a logical decision and
in the best interests of shareholders.
As previously communicated the company intends to undertake a further review
of the dividend policy at FY26. Any future dividend policy is expected to be based
on cash flow.
At March 2024, net interest bearing debt was $2.51 billion, up $210 million from
March 2023 however in-line with the position at September 2023. Total funding
headroom at March 2024 was $507.5 million (consisting of undrawn facilities and
cash).
Gearing of 36.2% has increased 3.1 percentage points reflecting both higher debt
and the impact on shareholders equity from valuation movements and
impairments. This sits slightly above our medium-term target of 30–35%.
The financial focus of the Board is to strengthen cash flow outcomes from
existing operations and to release capital from our inflight developments. Over
time, we aim to grow the value of Ryman whilst gradually reducing our net debt
position.
SLIDE 8: DEVELOPMENT PROGRESS
Turning to new developments, during FY24 we completed developments at both
John Flynn in Melbourne and William Sanders in Devonport. These are fabulous
new villages for our residents, with state-of-the-art amenities and a continuum
of care.
We also opened the main building at Deborah Cheetham in Ocean Grove,
welcoming residents into our sixth main building in Australia.
At year end, 10 villages were under active construction, including nine which had
already opened to residents. The current build programme is unusually skewed
to main buildings, of which four are expected to be completed in FY25.
Since year end, I’m pleased to announce that the main buildings at Miriam Corban
and James Wattie have both opened. Our village and regional teams have done
a fantastic job of operationalising these buildings which offer a wide range of
village amenities and are a key part of our value proposition for residents. Care
beds and serviced apartment units will now gradually fill over the next couple of
years with both new residents and existing Ryman residents who transition from
independent to more care-based offerings.
We are very focused on finishing the 10 inflight projects on time and at our
forecast cost which will allow us to repay bank debt as we sell down the
occupancy rights.
We have increased our focus on the efficiency of potential brand new village
developments, with a much stronger lens on expected cash recycling and net
present value. We expect to operate with a smaller land bank than we have been
carrying in the past and with a smaller number of developments underway at any
one time. We need to have the discipline to only start a development when we
know we have the financial capacity to finish it.
At March 2024 we had 5,371 units and beds available for development, including
2,627 at sites currently under active development, and 2,744 at our landbank
sites.
SLIDE 9: SUSTAINABILITY PROGRESS
Ryman is committed to our sustainability journey and decarbonising our
operations. We were pleased to have released our first Sustainability Report in
May this year which showcases progress across three priority areas: climate
change, quality care and Indigenous engagement. This report is available on our
website and I’d encourage you to read it.
During the year we announced that our greenhouse gas emissions targets have
been validated by the Science Based Targets initiative. This achievement has been
reached following Ryman formally setting an emissions reduction target of 42%
for scopes 1 and 2, to be achieved by 2030 relative to a base year of 2021.
We remain committed to reducing our environmental footprint. The
procurement of renewable electricity is a key initiative in our emissions
reduction plan. In 2023 we signed a long-term power purchasing agreement with
Solar Bay, through Mercury Energy. As part of this agreement, during FY24,
Ryman’s New Zealand electricity emissions were offset by renewable energy
certificates, which helped to materially reduce our New Zealand based
emissions.
In addition, in our 2024 Annual Report, we have published our first Climate-
Related Disclosures Report, as required by the New Zealand External Reporting
Board. The Disclosure Report outlines how we are embedding climate
considerations into our business model, as well as the impact our business has
on the climate.
SLIDE 10: RECOGNITION DURING THE YEAR
This year, Ryman celebrated a number of key achievements.
We were proud to open three new villages during the year, welcoming our first
residents into Northwood, here in Christchurch, Patrick Hogan in Cambridge
and Bert Newton in Australia.
In addition, we opened a new care centre at Deborah Cheetham in Melbourne,
finishing the year with 48 operating villages, home to some 14,600 residents.
We continued to be recognised by the industry for delivering great care and by
the community for their trust in our brand. We were proud to be named
Reader’s Digest Most Trusted Brand in aged care and retirement living in New
Zealand for the tenth time.
In addition, we won four awards at the 2024 Asia Pacific Eldercare Innovation
Awards, including ‘Operator of the Year – Ageing in Place’ for the second year
running.
We also continued to play an important role in our local communities, working
with our teams and residents to raise funds for the Fred Hollows Foundation
across New Zealand and Australia, who work tirelessly to put an end to
avoidable blindness.
SLIDE 11: FIT FOR THE FUTURE
We are committed to improving our financial performance.
As I mentioned earlier, we are focused on three key areas:
Firstly, improving the financial performance of our existing villages. We are
looking at both revenue and cost opportunities. What is the optimal mix of our
deferred management fee, weekly fees and services? On the cost side, how do
we match the operating efficiency of our best performing villages across our
whole portfolio?
Secondly, we need to improve the financial efficiency of our new village
developments. We have been unable to fully recycle our build costs with the
first sell down of Occupation Rights across 14 of our last 16 developments.
Many reasons have driven this including a combination of challenging land sites,
higher construction cost inflation than we anticipated, higher interest rates than
when developments were first started, greater overheads, our own changes to
scope once underway, or significant delays through either covid or financial
prudence.
This has come at a significant cost to shareholders. However, the best thing for
residents and shareholders now is to finish the current 10 developments to our
revised forecasts. I’m confident the team can do this.
In terms of NEW developments, we intend to delay putting any spades in the
ground until we are very confident that the new development can 100% recycle
capital.
Thirdly, we need to re-create a sustainable overhead structure that supports the
villages. We have over the last 8 years seen our support costs grow at a faster
rate than our unit and bed numbers. At Ryman we have to become leaner in
what we do.
All of these three areas are under current review. We know change is necessary
and we will be leaning into this in coming months. We will provide a further
update at our interim result in November.
SLIDE 12: AUDITOR
Ryman released its External Auditor Independence Policy in December 2023
providing guidance on the appointment and independence of the external
auditor. The Policy requires the tendering and formal assessment of the external
auditor at least every 10 years.
The Company’s current auditor, Deloitte, has been Ryman’s auditor since listing
on the NZX in 1999, a total of 25 years.
Deloitte has worked constructively with the Company as its auditor since this
time.
In accordance with the External Auditor Independence Policy, the Company
carried out a tender process overseen by Ryman’s Audit, Finance and Risk
Committee. Following a careful review and consideration of the responses, the
Committee recommended to the Board that PwC Auckland was the most
suitable appointment as the external auditor.
The Board agreed with the recommendation of the Audit, Finance, and Risk
Committee and seeks approval of the shareholders at today’s Annual Meeting
to the appointment of PwC Auckland as auditor for the financial year
commencing 1 April 2024.
The decision to recommend a change of auditor in no way reflects the
performance of Deloitte, or the services that they have provided to Ryman.
Ryman would like to thank Deloitte for the service they’ve given the Company
during their 25-year tenure.
SLIDE 13: AGED CARE FUNDING UNDER PRESSURE
Throughout the year, Ryman continued to advocate for change to the current
aged care funding models in both New Zealand and Australia.
As the ageing population expands and longevity increases, more older people
are occupying hospital beds and require care, putting huge pressure on
healthcare systems. As highlighted in the first phase of a Te Whata Ora Health
New Zealand commissioned review, the sector is facing unprecedented
challenges and financial pressures, leading to bed closures by some operators
and limited new builds despite growing demand.
Despite this independent review in their hands, Te Whata Ora, with limited
consultation, has provided only a 3.2% increase in funding for the sector for the
current year and said that they will provide financial support to weaker
operators on a case by case basis. We at Ryman don’t believe that is the right
answer. We question what measure of sustainability, let alone incentive for
growth, does that provide the broader sector which has some 37,000 care beds
– two thirds of which are in private or charitable hands.
We need Governments to acknowledge the crucial role the retirement living
sector has to play in meeting the housing and health needs of the growing
number of older people in both countries.
We believe the government needs to change the funding mechanism rather than
tinkering at the edges.
At Ryman, we believe that New Zealanders deserve to have a choice in the
products and services they receive as they age.
If it’s not fixed, aged care will inevitably become a broader healthcare issue.
Instead of paying $250/night to aged care providers, Te Whata Ora will be paying
$1,400 a night for a public hospital bed and blocking those beds from the general
public.
We’re optimistic that the new coalition Government will see the bigger picture
and create positive change to enable sustainable and equitable access.
In Australia, Ryman has been actively engaging with the Government on key
industry issues. It provided a submission to the Aged Care Task Force, which
subsequently provided recommendations to the Government in March 2024,
including support for a co-contribution model. We are hopeful of bi-partisan
support being reached in current negotiations. The changes proposed will be a
positive sign for the industry and make investing in new aged care assets in
Australia potentially more attractive than in NZ.
SLIDE 14: FY25 OUTLOOK
Looking ahead.
Current economic conditions remain challenging in both New Zealand and
Victoria, and it is unclear when interest rates will begin to decline and support
improved housing market conditions and liquidity.
Incoming residents to independent retirement living in most cases need to sell
their home to fund the Occupation Right upon entry - and as a result residential
market conditions have an impact on timing and affordability for potential new
residents. Most market commentators are expecting tough housing market
conditions to continue for the balance of calendar 2024.
At Ryman we can do little about those external factors, however we do need to
be focused on improving our own performance. There continues to be demand
for living in a Ryman village, as evidenced by strong demand for our independent
living units (noting that we achieved over 1,500 ORA sales in the last financial
year), our high care bed occupancy at our mature villages and the growing
occupancy at our new care facilities.
We are assuming that tough housing market conditions will continue for the
balance of our financial year.
In my mind, market conditions simply reinforce our need to get fit for the future.
Our guidance for the full year remains unchanged:
- To be cash flow positive
- To build 850-950 retirement village units and aged care beds
- To spend between $700-$820 million on capex
Your Board is positive about the future of Ryman. We are energised by the need
for change and are committed to improving Ryman’s financial performance whilst
at the same time maintaining great care and experience for our residents.
Thank you for your time.
SLIDE 15: RESOLUTIONS
Before we move to general business and your opportunity to ask any questions,
we will now move to the formal meeting resolutions which were outlined in the
Notice of Meeting.
Each resolution set out in the Notice of Meeting is to be considered as an
ordinary resolution and, as such, must be approved by a simple majority of the
votes cast by shareholders entitled to vote and voting on the resolution.
A poll will be held on each of today’s three resolutions.
For those of you here today, you will be voting using your voting card. Please
mark your voting intention for each resolution and the voting cards will be
collected at the conclusion of the meeting.
If you require assistance with this, please see MUFG outside the room.
For those of you voting online, you will need to click “Get Voting Card” within
the online meeting platform.
Please mark your electronic voting card in the way you wish to vote by clicking
“FOR”, “AGAINST” or "ABSTAIN".
Once you have made your selection please click “Submit Vote” on the bottom
of the card to lodge your vote.
Please refer to the virtual meeting online portal guide or use the help line
specified if you require assistance.
A quick reminder that voting will remain open until 5 minutes after the
conclusion of the meeting.
Results of the vote will be announced via the NZX.
The outcome of proxy votes received prior to the meeting, will be displayed for
your information after voting on all the resolutions.
There will be an opportunity for shareholders to ask questions on each matter
being put to shareholders. For the sake of good order, shareholders questions
raised should relate directly to the matter being considered. There will be a tine
later to ask general questions.
When I call for questions, can shareholders present in the room please wait until
a microphone is provided to you and clearly state your name.
I will take questions from those present in the meeting first before moving onto
any questions from shareholders online.
I ask that in the interest of fairness to all shareholders attending this meeting,
that anyone wishing to ask questions be as concise as possible and be
considerate of other shareholders wishing to ask questions.
SLIDE 16: RESOLUTION 1 – AUDITOR’S APPOINTMENT &
REMUNERATION
Turning to resolution 1...
Pursuant to section 207P(2) of the Companies Act 1993 the Board seeks
approval of the shareholders to the appointment of PwC Auckland as the auditor
of the Company and pursuant to section 207S of the Companies Act 1993 to
authorise the Board to fix the auditor’s remuneration for the ensuing year.
The Board unanimously supports the appointment of PwC Auckland as the
external auditor.
Are there any questions of the Board concerning the resolution from
shareholders in the room?
Are there any questions online?
I now propose that PwC Auckland is appointed as auditor of the Company and
that the Board is authorised to fix the auditor’s remuneration for the ensuing
year.
Please mark your voting cards in the way you wish to vote by ticking “FOR”,
“AGAINST” or "ABSTAIN" in the appropriate place on the voting card.
SLIDE 17: RESOLUTION 2 – RE-ELECTION OF KATE MUNNINGS
Turning to resolution 2...
Under NZX Listing Rule 2.7.1 a director appointed by the Board must not hold
office (without re-election) past the next Annual Meeting following the director’s
appointment. Kate Munnings was appointed as a non-executive director by the
Board with effect from 1 November 2023. Kate accordingly retires and offers
herself for re-election. Kate is considered by the Board to be independent. The
Board unanimously supports the re-election of Kate.
Kate accordingly retires and offers herself for re-election. She will now
introduce herself.
[Kate]
Good morning, my name is Kate Munnings. I joined the Ryman Healthcare Board
in November 2023, and today seek your support for re-election.
Ryman Healthcare is an iconic New Zealand company and I am honoured to
have an opportunity to serve you on the company’s Board. Thank you for the
opportunity to share what I hope to bring to the Ryman Board and the wider
Ryman family.
My career has been quite diverse, but I think it marries nicely with the needs of
Ryman, at this stage of the company’s history.
I started my career, many years ago, as an assistant in nursing, and spent 3 years
working in aged care. I generally worked night duty because I was training to be
an RN, so I spent many nights talking with residents about their lives and
experiences, as well as providing residents and their families nursing care and
support. So I bring to Ryman front line experience in caring for residents, and I
have a deep understanding of how important that responsibility is for a company
like Ryman.
I then became an RN and specialised in HIV/AIDS nursing. AIDS patients in the
80’s were ostracised and isolated, often for reasons that had nothing to do with
their disease. That experience, led me to study law and I left one of the most
loved professions and joined one of the least loved, when I became a solicitor in
the early 90’s.
I spent 12 years in private legal practice, specialising in construction law. I
progressed to partner and had a leadership role in the construction practice at
the international law firm Baker McKenzie. I spent those years in private practice,
solving complex legal and commercial problems for my clients. So, I bring to
Ryman an understanding of legal issues in the property and construction sector,
as well as experience in solving the complex legal problems.
I then left private practice and spent 8 years at ASX listed Transfield Services as
their Chief Risk & Legal Officer and Company secretary, doing extensive
international M&A and corporate governance advisory work, across Australia,
NZ, US, Canada, Chile and UAE. This was a dramatic change, as in that role, I
was a corporate lawyer, advising an ASX listed board on their responsibilities as
directors; developing and managing an enterprise risk management program and
running large international acquisitions. So I bring to Ryman an understanding of
corporate law, risk management and corporate governance.
When I eventually moved into an operations role, I was responsible for
Transfield Services construction, logistics and consulting businesses across
Australia and NZ. This included providing facilities management in complex
environments such as social housing, schools and defence bases. My business
unit was also responsible for rolling out the NBN in Australia and the fibre
rollout for Enable in Christchurch. So, I bring to Ryman operational experience
in running a facilities management and logistics business in sensitive
environments, as well as experience in running a construction business which
included a large infrastructure project in Christchurch.
After about 23 years working outside of healthcare, I return to the sector about
10 years ago. Since then, I have been running large health care organisations, first
as COO at Ramsay Health Care and then as CEO of Virtus Health Care. So, I
bring to Ryman operational and leadership experience in running large, complex
health services, where I was required to balance the need to provide exceptional
patient care, with sustainable commercial performance.
Importantly, I have also led a number of transformation programmes. They
include a significant transformation programme across Ramsay’s hospital
network - where I was responsible for 73 public and private hospitals; another
programme across 46 ART clinics that spanned 5 countries; and I also guided a
transformation programme from a board role across 8 hospitals and multiple
primary health networks at South East Sydney Local Health District. So, I bring
to Ryman experience in delivering results from transformation programs in large
complex healthcare environments.
My experience also includes delivering impact from a governance role. I have
previously been a director of South-Eastern Sydney Local Health District and
Ramsay Hospital Research Foundation. I currently Chair the Digital Health CRC,
and from today, a few weeks ago, it was announced that I have been appointed
to the Board of Wesfarmers Limited, an iconic company with operations across
Australia and New Zealand. So, I bring to Ryman governance experience as a
director of large and complex organisations.
I commit to you, that I will bring all that I have learned over my career to the
Ryman Board; I will help to support and guide the Ryman team and I will work
extremely hard to ensure that Ryman delivers on its ambition of providing
exceptional care to residents; and exceptional returns to shareholders.
[Dean]
Thank you, Kate...
Are there any questions for Kate or the Board concerning this resolution from
shareholders in the room?
Are there any questions online?
I now propose that Kate Munnings be re-elected a director of the company.
Thank you – please mark your voting cards in the way you wish to vote by ticking
“FOR”, “AGAINST” or "ABSTAIN" in the appropriate place on the voting card.
SLIDE 18: RESOLUTION 3 – RE-ELECTION OF DAVID PITMAN
Now turning to resolution 3...
Under NZX Listing Rule 2.7.1 a director appointed by the Board must not hold
office (without re-election) past the next Annual Meeting following the director’s
appointment. David Pitman was appointed as a non-executive director by the
Board with effect from 1 May 2024. David accordingly retires and offers himself
for re-election at the 2024 Annual Meeting. David is considered by the Board to
be independent. The Board unanimously supports the re-election of David.
David accordingly retires and offers himself for re-election. He will now
introduce himself.
[David]
Thank you Dean.
Good morning. My name is David Pitman; I joined the Ryman Board on 1 May
2024 and today I seek your support for re-election.
As this is my first time before you, it seems appropriate to give you a sense of
my background.
I have accumulated 40 years’ experience in general, operational and financial
management, strategy development and M&A in Executive and Consulting roles.
My undergraduate training was at the University of Sydney where I earned a
Bachelor of Aeronautical Engineering, which led to a nine-year career in the
aviation sector, holding commercial management roles in Sydney and Los
Angeles with responsibilities for aircraft maintenance and product support
businesses.
Wishing to broaden my career, I undertook an MBA at the University of NSW,
from which I was chosen to attend the Wharton School in Philadelphia on
exchange. Upon completing my degree, I joined the Boston Consulting Group,
where I remained for 12 years advising on a diverse range of issues from
competitive strategy through to transformation across many industrial sectors
including financial services, industrial goods, airlines, forestry and consumer
products. I served clients in Australia and New Zealand and also in the USA,
being based in Los Angeles again for a period of time.
I became a Partner of the Global firm in 2003 and, having developed an expertise
in shareholder value management, I was chosen to lead the Corporate Finance
and Strategy practice in the Asia Pacific region.
In 2007, I transitioned to Stockland Corporation as EGM Strategy and Corporate
Development, later assuming the role of CEO of Stockland’s Retirement Living
division.
In that role, I led a transformation of the Retirement business, growing the
portfolio from 24 Melbourne-focused villages to a national network of 62 villages
through a combination of organic development and acquisition. Cash profitability
was restored and grown in both established operations and in new village
development and the culture of the organisation became more performance-
oriented, while retaining high levels of resident satisfaction and employee
engagement, outperforming the relevant external benchmarks.
After more than six years at Stockland, I returned to BCG as a Partner again,
this time in Boston, Massachusetts, as Global Finance Director, overseeing the
firm’s finance operations, accounting and control across 50 countries. I
subsequently relocated back to Sydney in 2018 with my family, assuming a senior
advisor role at BCG before moving into private consulting.
I am excited to have the opportunity to be involved with Ryman, a business
which has earned a reputation for outstanding resident care and high-quality
villages. The business is now undergoing a transformation and, as one of your
representatives on the Board, I can say I am personally committed to seeing that
we maintain our record of great Care while driving a material improvement in
shareholder value.
If elected today, I look forward to leveraging my experience in finance, strategy,
property and retirement living to help achieve that goal.
I would appreciate your support to be re-elected as a Director of Ryman.
[Dean]
Thank you, David...
Are there any questions for David or the Board concerning this resolution from
shareholders in the room?
Are there any questions online?
I now propose that David Pitman be re-elected a director of the company.
Thank you – please mark your voting cards in the way you wish to vote by ticking
“FOR”, “AGAINST” or "ABSTAIN" in the appropriate place on the voting card.
SLIDE 19: GENERAL BUSINESS
I would now like to give shareholders the opportunity to ask questions - whether
related to the presentations, the Financial Statements, or the management of the
company. We will do our best to answer these.
Shareholders online can continue to provide questions through the portal, and
we will also address questions from the room.
If you are asking a question from the floor please state your name, whether you
are a shareholder, or if a proxy holder, the name of the shareholder represented.
Please wait until we bring a microphone to you – so that the people in the room
as well as online can hear you clearly.
Do we have any questions in the room?
Do we have any questions online?
SLIDE 20: THANK YOU
We are now nearing the end of today’s meeting.
In looking ahead, 2024 is a significant year for Ryman marking our 40th
anniversary since opening our first village in New Zealand, our 10-year
anniversary since opening our first village in Victoria, and our 25th anniversary
of being listed on the NZX.
We have an exciting future ahead. Over the next 30 years, New Zealand's
population of seniors aged 65+ will grow from around 850,000 to around 1.5
million. In Australia, by 2066, it is projected that older people will make up
around 23% of the total population.
Ryman is well placed to benefit from this ongoing demographic change. We have
an industry-leading reputation in retirement living and care. We have scale with
48 operating villages across New Zealand and Victoria.
We have over 14,600 residents and a high satisfaction rating by our residents of
their Ryman experience. Importantly, we have a strong sense of purpose
amongst our 7,700 team members.
The next 12 months will be challenging however the business is here for the
long-term. We need to make the changes now so that when conditions improve
we are much fitter and much better placed to capitalise.
Before I close the meeting I would like to acknowledge and thank our people
and teams. You make our culture unique and are integral to the success of our
business. It is your hard work and dedication that ensures our residents have a
great experience.
I would also like to say a very special thank you to our shareholders. We’re
grateful for your on-going support and your confidence in our capacity to deliver
in the future.
I would like to thank my fellow directors who I know are all very focused on
improving the financial performance of your company.
We are committed to balancing care with commerciality. We know we need to
improve the profitability of our operations and the efficiency of our new
developments. We are very focused on getting Ryman fit for the future.
Now, I invite you all to join us for refreshments and an opportunity to catch up.
We have our senior leadership team here as well and so please take the
opportunity to introduce yourself to directors and management. For
shareholders in the room, please pass your voting cards to MUFG Corporate
Markets representatives as you exit.
Thank you.
End of Meeting
Contacts:
For investor relations information contact Hayden Strickett, Head of Investor Relations, on
027 303 1132 (+64 27 303 1132) or email hayden.strickett@rymanhealthcare.com.
For media information or images contact Silke Marsh, Group Corporate Affairs Manager, on
027 294 3609 (+64 27 294 3609) or email silke.marsh@rymanhealthcare.com.
---
R Y M A N H E A L T H C A R E
Annual Shareholder
Meeting
1 August 2024
R Y M A N H E A L T H C A R E |2024 Annual Shareholder Meeting2
Keith Park Village resident Mary and her grandson.
Agenda
2
Welcome and introductions
Executive Chair’s address
Resolutions
General business
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting3
Virtual meeting instructions
R Y M A N H E A L T H C A R E | 2024 Result Presentation4
Deborah Cheetham Village.
4
Executive Chair’s
address
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting5
Retiring in 2024
Elected at 2023 ASM
Up for re-election at 2024 ASM
Board of directors
Elected in prior years
Geoffrey Cumming
NON-EXECUTIVE
DIRECTOR
Joined 2018
Claire Higgins
NON-EXECUTIVE
DIRECTOR
Joined 2014
Dean Hamilton
EXECUTIVE
CHAIR
Joined 2023
James Miller
NON-EXECUTIVE
DIRECTOR
Joined 2023
Kate Munnings
NON-EXECUTIVE
DIRECTOR
Joined 2023
David Pitman
NON-EXECUTIVE
DIRECTOR
Joined 2024
Anthony Leighs
NON-EXECUTIVE
DIRECTOR
Joined 2018
Paula Jeffs
LEAD INDEPENDENT
DIRECTOR
Joined 2019
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting6
FY24 financial performance
Cash flow from
development activity
1
($230.2m)
Up $150.8m | FY23: ($381.0m)
Net profit after tax
(NPAT)
$4.8m
Down 98% | FY23: $257.8m
Cash flow from existing
operations
1
$43.3m
Up $51.8m | FY23: -$8.5m
IFRS profit before tax and fair
value movements (PBTF)
($324.5m)
Down -$99.2m | FY23: ($225.3m)
Per share: (47.2cps) | FY23: (43.6cps)
Total one-off costs
1
($283.9m)
FY23: ($175.4m)
1Cash flow from existing operations, cash flow from development activity, free cash flow and one-off costs are non-GAAP (Generally Accepted Accounting Principles) measures and do not have a standardised meaning
prescribed by GAAP, and so may not be comparable to similar financial information presented by other entities
Key metrics
Free cash flow
1
(CFEO + CFDA)
($186.9m)
Up $202.6m | FY23: ($389.6m)
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting7
Capital management
Note all figures are FY24 unless otherwise stated.
1Net interest-bearing debt, funding headroom and gearing are non-GAAP (Generally Accepted Accounting Principles) measures and do not have a standardised meaning prescribed by GAAP, and so may not be
comparable to similar financial information presented by other entities
2NTA per share is calculated as total equity less intangible assets and deferred tax asset, divided by shares on issue.
3Gearing is calculated as net interest-bearing debt to net interest-bearing debt plus total equity.
Net interest-bearing debt
1
$2.51b
Up $0.21b | FY23: $2.30b | 1H24: $2.47b
Gearing
1,3
(debt to debt plus equity)
36.2%
Up 3.1pp | FY23: 33.1%
Total equity
equity
$4.42b
Down $0.24b | FY23: $4.66b
NTA per share
2
: $6.015
Funding headroom
1
(including cash)
$507.5m
Down $69.7m | FY23: $577.2m
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting8
Keith Park main building under construction
Photo, 10 July 2024
Bert Newton main building under construction
Photo, 17 June 2024
Miriam Corban main building opened May 2024
Photo, 1 May 2024
James Wattie main building opened June 2024
Photo, 4 July 2024
Development progress
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting9
Sustainability progress
•We remain committed to our sustainability
journey and decarbonisingour operations
•Released our first Sustainability Report
inMay 2024
•In March 2024, our greenhouse gas
emissions targets were validated by the
Science Based Targets initiative (SBTi)
•Our first Climate-related Disclosures were
released in our FY24 Annual Report
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting10
Recognition during theyear
•Opened three new villages during FY24,
welcoming our first residents into
Northwood(Christchurch), Patrick Hogan
(Cambridge) and Bert Newton (Australia)
•NamedReader’s Digest Most Trusted Brand
in aged care and retirement living in
New Zealand for the tenth time
•Winner offour awards at the 2024 Asia Pacific
Eldercare Innovation Awards, including
Operator of the Year –Ageing in Place’
for the second year running
Miriam Corban Village resident, Keri.
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting11
Fit for the Future
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting12
Auditor
•External Auditor Independence Policy published
on 1 December 2023
•The rotation of audit firm will be tendered at least
every 10 years
•PwC recommended by the Board to be appointed
as auditorforthe financial yearcommencing
1 April 2024
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting13
Aged care funding under pressure
•Throughout the year, Ryman continued to advocate
for change-governments need to urgently address
the models to ensure sustainability of the sector
•Current aged care funding models not working in
New Zealand and Australia, leading to bed closures
and limited new builds in the face of growing demand
•TeWhataOra has provided only a 3.2% increase in
funding for the sector for the current year
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting14
FY25 outlook –unchanged fromfull year result
Cash flowWe continue to target positive free cash flow (representing the combination
of cash flow from existing operations and cash flow from development activity)
CapexWe expect to spend $700–820 million on capex , including:
•$600–700 million on development activity
•$100–120 million on existing operations
Completed build
rate
1
We expect to complete 850–950 retirement village units and aged care beds,
which includes:
•650 aged care beds and serviced apartments in four main buildings that will
be opened
•200-300 independent retirement village units
1Includesunits and beds reported at March 2024 as near complete
R Y M A N H E A L T H C A R E | 2024 Result Presentation15
Resolutions
Residents John and Bev at our Northwood Village.
15
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting16
Resolution 1
Auditor’s appointment and remuneration
That PwC Auckland is appointed as the auditor
of the Company and that the Board is authorised
to fix the auditor’s remuneration for the
ensuing year.
Artist’s impression of our Mulgrave Village.
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting17
Under NZX Listing Rule 2.7.1 a director appointed by
the Board must not hold office (without re-election)
past the next Annual Meeting following the director’s
appointment.
Ms Kate Munnings was appointed as a non-executive
director by the Board with effect from 1 November
2023. Ms Munnings accordingly retires and offers
herself for re-election at the 2024 Annual Meeting.
Ms Munnings is considered by the Board to be
independent.
Resolution 2
Re-election of Ms Kate Munnings
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting18
Under NZX Listing Rule 2.7.1 a director appointed by
the Board must not hold office (without re-election)
past the next Annual Meeting following the director’s
appointment.
Mr David Pitman was appointed as a non-executive
director by the Board with effect from 1 May 2024.
Mr Pitman accordingly retires and offers himself for
re-election at the 2024 Annual Meeting. Mr Pitman
is considered by the Board to be independent.
Resolution 3
Re-election of Mr David Pitman
R Y M A N H E A L T H C A R E | 2024 Result Presentation19
General business
Artist’s impression of our Bert Newton Village.
19
R Y M A N H E A L T H C A R E | 2024 Result Presentation20
Caregivers at our Anthony Wilding Village.
Thank you
20
R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting21
Disclaimer
This presentation has been prepared by Ryman
Healthcare Limited and its group companies
("Ryman") for informational purposes.This
disclaimer applies to this document and the
verbal or written comments of any person
presenting it.
This presentation provides additional comments
on the full year result for the period to 31 March
2024 presented on 27 May 2024.It should be read
in conjunction with all other material which we
have released, or may release, to NZX from time
to time. That material is also available on our
website at rymanhealthcare.com.
Ryman disclaims and excludes all liability for any
loss suffered by any person as a result of the use
of or reliance on the information contained in,
or omitted from, this presentation, and makes
no representation or warranty as to the currency,
fairness, accuracy, completeness or reliability
of the information contained in this presentation,
in each case to the fullest extent permitted
by law.
Purpose of this presentation
This presentation isnot an offer of financial products, or a proposal or invitation to make
any such offer.It is not investment advice, or any otheradvice, or a recommendation
in relation to financial products, and does not take into account any person’s individual
circumstances or objectives. Every investor should make an independent assessment
of Ryman on the basis of expert financial advice.
Forward-looking statements
This presentation contains forward-looking statements and projections.These reflect our
current expectations, based on what we think are reasonable assumptions.However,
any of these forward-looking statements or projections may be materially different due
to a range of factors and risks. Ryman gives no warranty or representation as to our future
financial performance or any future matter.Actual results may differ materially from
those projected.Except as required by law or the NZX Listing Rules, Ryman undertakes
no obligation to update any forward-looking statements whether as a result of new
information, future events, or otherwise.
Non-GAAP information
A number offinancial measures used in this presentation are based on non-generally
accepted accountingprinciples (i.e.non-GAAP financial information).This includes,
in particular, our ‘underlying profit’ which Ryman has used for many years as a means
of showing our profit absent any unrealised valuation movements.We show our underlying
profit together with our reported profit based on NZ IFRS (a GAAP measure). You should
not considerany of these statements in isolation from, or in substitution for the information
provided in the Financial Statements for the 12 months ended 31March 2024.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- CVT — Comvita Limited: Comvita 2024 Annual Shareholders' Meeting2024-10-29
“NEXT SLIDE As you know, you will see some new faces on both the Board and management team today. On the Board, David Banfield has now left the company and Brett Hewlett has stepped into the CEO role in David’s place. Luke Bunt has rejoined the Board, formerly our Chair of Au…”
- SCL — Scales Corporation Limited: 2024 Annual Shareholders' Meeting Presentations2024-06-05
“3 You may submit questions on each resolution being put to shareholders using the question process. For those of you who have joined us in person, those Shareholders who are entitled to vote and proxies who have discretion as to how they vote, should have received a Votin…”
- 2CC — 2 Cheap Cars Group Limited: 2CC ASM Presentation2024-09-26
“1 280926 2CC ASM SCRIPT FINAL SLIDE 1 – 2CC 2023 ANNUAL SHAREHOLDERS’ MEETING Michael Stiassny Mōrena, good morning. My name is Michael Stiassny, Chairman of 2 Cheap Cars Group Limited. As it’s now 10.00am, I am pleased to open the 2 Cheap Cars Annual Shareholders’ Me…”